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Background: The outgrowth of the vertebrate limb bud
is the result of a reciprocal interaction between the mesen-
chyme and a specialized region of the ectoderm, the apical
ectodermal ridge (AER), which overlies it. Signals eman-
ating from the AER act to maintain the underlying mes-
enchyme, called the progress zone, in a highly proliferative
and undifferentiated state. Removal of the AER results in
the cessation of limb bud growth, thus causing limb trun-
cation. The best candidates for this AER-derived signal
are members of the fibroblast growth factor (FGF) family,
in particular FGF-4, which can maintain limb bud out-
growth following removal of the AER. However, FGF-4
is only expressed after considerable outgrowth has occur-
red and a well-developed limb bud has formed, and then
only in the posterior part of the AER. Likewise, the other
FGFs studied to date are not candidates for this activity.
Results: We report evidence that a recently identified
member of this family, FGF-8, is expressed in the ecto-
derm of the prospective limb territory prior to morpho-
logical outgrowth of the limb bud in both mouse and
chick. Thereafter, expression is maintained throughout
the AER during limb development. We have produced
and purified the FGF-8 protein, and shown that it will
substitute for the AER in maintaining limb bud out-
growth in mouse embryos from which the AER has been
surgically removed. FGF-8 does not, however, maintain
expression of the sonic hedgehog gene.
Conclusions: These results indicate that FGF-8 is an
AER-derived mitogen that stimulates limb bud out-
growth. Moreover, our data suggest that FGF-8 may also
be an ectodermally derived mitogen that stimulates the
onset of limb bud outgrowth (budding) in the absence of
a morphological AER, and indicate the possible involve-
ment of FGF-8 in the establishment of the limb field.
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Introduction
The fibroblast growth factor (FGF) family presently has
nine known members. Most aresecreted constitutively,
but there is evidence that members of the family that
lack a conventional signal sequence - FGF-1, FGF-2
and FGF-9 - can also be secreted, possibly by novel
mechanisms. These cytokines transduce a signal through
a family of transmembrane receptor tyrosine kinases, the
FGF receptors (FGFRs). In addition, they bind with
lower affinity to glycosaminoglycans and proteoglycans
associated with the cell surface and extracellular matrix;
this interaction may be obligatory for FGFR activation
(see [1] for a recent review and references). Studies per-
formed both in vitro and in vivo indicate that FGFs can
modulate a wide range of developmental processes. They
are mitogens for cells of all three germ layers and have
been implicated in mesoderm induction, vascularization
and the development of muscle, teeth and limbs (re-
viewed in [2]). Their effects on neural tissue include
stimulation of neurite outgrowth, promotion of survival
and induction of differentiation (reviewed in [3]). In vivo,
experiments in which FGF or FGFR function are com-
promized have led to the identification of their roles in
gastrulation and otocyst and tail development, as well as
during hair production and epithelial branching mor-
phogenesis (reviewed in [1]; see also [4-6]).
FGF-8 - previously known as androgen-induced
growth factor - was first identified as a heparin-binding
mitogen induced by androgens in a breast cancer cell line
[7]. Thefgf-8 gene is located on chromosome 19 in the
mouse [8] and, in common with other FGFs, FGF-8 has
transforming activity in vitro [9]. Comparison of its pre-
dicted amino-acid sequence with those of other FGFs
shows that FGF-8 is the most divergent member of this
family, suggesting that it might regulate developmental
processes not previously associated with FGFs. To begin
to identify potential developmental functions for this
gene, we have isolated a fgf-8 cDNA and examined the
expression of fgf-8 transcripts in the mouse embryo.
While this manuscript was in preparation, fgf-8 RNA
expression patterns during mid-gestation, determined by
in situ hybridization to whole mouse embryos, were
published [10,11]. In this paper, we extend these studies
to both younger and older embryos and, additionally,
report new sites offgf-8 expression during the mid-ges-
tation period. We further extend the published work by
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providing novel histological data, characterizing a new
fgf-8 splice variant and demonstrating tissue-specific reg-
ulation of exon usage. We show thatfgf-8 is expressed in
the apical ectodermal ridge (AER) of both mouse and
chicken embryos from the onset of limb bud formation,
and that purified FGF-8 protein rescues limb bud out-
growth in mouse limbs lacking an AER.
Results and discussion
Fgf-8 expression in the postimplantation mouse embryo
A mouse fgf-8 cDNA was isolated by the reverse-tran-
scription-coupled polymerase chain reaction (RT-PCR)
technique, as described in Materials and methods, and was
used to generate antisense riboprobes for in situ hybri-
dization to whole embryos and tissue sections. Following
implantation, fgf-8 transcripts were first detected in the
visceral embryonic ectoderm, but not the visceral extra-
embryonic ectoderm, of 5.5 d.p.c. (days post-coitum)
embryos (Fig. la). At the onset of gastrulation, expression
was also observed in the region of the developing primi-
tive streak in both the ectoderm and mesoderm (Fig.
lb,c), but not in anterior ectoderm. In older embryos,
expression was maintained in all but the most anterior part
of the primitive streak (Fig. ld-f), a region from which
paraxial, lateral and extraembryonic mesoderm are derived
[12], and in the tail bud at later stages (Fig. lg,h; [11]).
In situ hydridization to tail bud sections showed thatfgf-8
transcripts were present in cells of all three germ layers:
the ectoderm (including the neural plate), mesoderm and
endoderm (Fig. li-k); this distribution was also observed
at primitive streak stages (data not shown). These findings
are in contrast to a recent report which suggested that
fgf-8 transcripts were absent from the mesoderm in the
streak region [11]. Other FGFs -fgf-3, fgf-4 andfgf-5-
have also been detected in the primitive streak region of
the mouse, with overlapping but different domains of
expression [13-15]. Studies in amphibian embryos have
implicated FGFs in the induction of the ventral meso-
derm during gastrulation (see [16] for review). However,
targeted disruption of the fgf-3 and fgf-5 genes does not
result in the loss of any mesodermal derivative in the
mouse embryo [4,5]. Moreover, inhibition of FGFR func-
tion in Xenopus embryos does not result in the loss of
particular ventral mesoderm tissues, but rather in a com-
plete absence of posterior regions of the embryo [17],
indicating functions in posterior development rather than
mesoderm induction per se.
At the onset of somitogenesis (8 d.p.c.), complex fgf-8
expression was observed in the prospective cranial region.
Transcripts were detected in a region of prechordal
neuroepithelium, prechordal floorplate, the cardiogenic
plate, endoderm around the intraembryonic coelom and
in a restricted region of the cranial paraxial mesoderm
and the overlying ectoderm (Fig. d and data not shown).
Expression in these regions was transient, although
lower RNA levels were detected in the myocardium of
8.75 d.p.c. embryos (Fig. 11). RNA was also transiently
detected in developing somites. RNA was first observed
in anterior somites at the 15 somite stage (9 d.p.c.; data
not shown), and subsequently detected in all somites dur-
ing their development, but by 10.5 d.p.c. expression was
restricted to tail somites (data not shown). Inspection of
whole embryos revealed that transcripts had an unusual
distribution, occurring as two dorso-ventrally oriented
stripes within each somite (Fig. lg,h). Transverse sections
showed that these domains were restricted to the rostral
and caudal regions of the somitic myotome (Fig. lm).
Other FGFs are also expressed in the myotome -fgf-5,
fgf-6 and fgf-7 transcripts are detected throughout this
region in mice [18-21] and FGF-2 has a similar distribu-
tion in the chicken [22]. By contrast, fgf-4 RNA has a
complementary pattern of expression to that offgf-8 -
it is restricted to the most medial region of the myotome
in the rostro-caudal axis [14]. Dorso-ventral differences
in the expression of proteins encoded by myogenic genes
- myf-5, MyoD, mrf-4 and myogenin - in murine
somitic myotome have recently been described [23].
Interestingly, these authors also show rostro-caudal
differences in expression: although myf-5 is expressed
throughout the dorsal myotome, myogenin and mrf-4 are
expressed only in the central stripe, as observed forfgf-4;
MyoD expression is restricted to the same region in the
ventral myotome. Thus, expression of the myogenic and
fgf genes seems to reveal new spatial domains within the
craniocaudal axis of the myotome.
Potential roles in the stimulation of division and inhibi-
tion of differentiation of both cardiac and skeletal myo-
blasts are well known (see [21] for discussion and refer-
ences). However, studies of FGFRs in developing somites
reveal differential expression in the dermatome, sclero-
tome and myotome [24-26]. It therefore seems likely
that FGF expression in the myotome also influences the
development of the adjacent dermatome and sclerotome
in addition to the myotome itself.
Regional expression offgf-8 was detected in the develop-
ing brain. Notably, from as early as the four-somite stage,
transcripts were found in the region of the prospective
midbrain (Fig. le), becoming restricted to the midbrain-
hindbrain boundary region (isthmus) from the 12-
somite stage until 11 d.p.c. (Fig. lf,g and data not shown)
[10,11]. Sections of the isthmus showed that transcripts
were expressed throughout the neuroepithelium, with
the exceptions of the floorplate and roofplate (Fig. ln,o).
Fgf-8 RNA was also found in the dorsal region of the
midbrain-forebrain boundary (Fig. lh,p) and at the ros-
tral tip of the telencephalon around the neuropore (Fig.
lf,g,p) [10,11]. Although the latter region gives rise to
the olfactory bulb, analysis of older embryos showed that
transcripts extend over a region greater than just that
encompassing the olfactory bulb primordium (Fig. lu).
In addition, fgf-8 expression was observed in the region
of the developing infundibulum at 10.5 d.p.c. (data not
shown), as reported by others [10]. By 14.5 d.p.c., RNA
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was no longer detected in the forebrain or at the mid-
brain-hindbrain boundary but was detected in the ven-
tricular zone of the ventro-posterior midbrain (Fig. lq).
Fgf-8 is expressed in two neuromeric boundary regions of
the brain. Interestingly, we have recently shown thatfgf-3
transcripts become restricted to the boundaries between
hindbrain rhombomeres in both chicken and mouse
embryos and are also detected at the midbrain-hindbrain
boundary ([27] and R.M., I.M. and G. Morriss-Kay,
manuscript submitted). This suggests that FGFs are invol-
ved in the regulation of properties characteristic of boun-
dary regions within the developing brain, such as the
preferential accumulation of axonal processes (reviewed in
[28]). FGF-8 may also play a role in the regulation of the
spatial organization of the midbrain, as it is a good candi-
date for a midbrain-hindbrain boundary signalling mol-
ecule, which has been implicated in posterior midbrain
development and maintenance of En2 expression (for
example, see [29]).
In agreement with the results of others [10,11], we detec-
tedfgf-8 expression in the facial ectoderm. We also obser-
ved spatially restrictedfgf-8 expression in the pharyngeal
endoderm. Fgf-8 RNA was detected in the facial ecto-
derm adjacent to, and continuous with, that in the rostral
forebrain (Fig. lf,p; [10,11]), but at later stages expression
became restricted to the olfactory pits (Fig. lu) and was
present in the olfactory epithelium at 14.5 d.p.c. (data not
shown). In addition, transcripts were initially found in the
ectoderm of the caudal region of the lateral nasal process
and the rostral part of the first arch, and subsequently in
the caudal region of the maxillary process, the rostral
mandibular process and throughout the ectoderm of the
posterior branchial arches (Fig. lr-t; [10,11]). Expression
was also observed in the endoderm of all three pharyngeal
pouches but not in the medial endoderm of the pharynx
(Fig. ls,t and data not shown).
Interestingly, fgf-8 transcripts were detected in the pre-
sumptive arch ectoderm and presumptive pharyngeal
pouch endoderm before the morphological appearance
of the arches themselves (Fig. f and data not shown).
Temporally, fgf-8 RNA was first detected in the bran-
chial region as early as the four somite stage (Fig. le)
and persisted until 10.5 d.p.c. (data not shown) [11].
The spatial and temporal distribution offgf-3 andfgf-4
transcripts in the branchial region is very similar to that
offgf-8 ([14,15,30] and R.M., I.M. and G. Morriss-Kay,
manuscript submitted), and these molecules may be
involved in epithelial-mesenchymal interactions during
morphogenesis of the facial region.
At 12.5 d.p.c.,fgf-8 expression was detected in the prim-
itive glomeruli of the developing kidney and this per-
sisted until at least 16.5 d.p.c. (Fig. lv and data not
shown); however, it could not be determined whether
transcripts were localized to the capillaries or podocytes.
Fgfr-I RNA is also detected in developing glomeruli
[26], suggesting a possible regulatory role for fgf-8 in
their development. Taken together, these data and those
concerning developing limbs (see below) both confirm
and significantly extend the recent findings of others
[10,11,31]. In addition, unpublished studies of fgf-8
expression in the chicken embryo suggest a near com-
plete conservation offgf-8 expression patterns (N.M. and
I.M., manuscript in preparation).
Characterization of a novel fgf-8 splice variant and
tissue-specific variation in RNA splicing
Analysis of the fgf-8 cDNA sequence revealed an open
reading frame of 204 nucleotides, smaller than those pre-
viously described (Fig. 2a) [7,10]. The difference is due
to the absence of an exon which, in other variants,
encodes additional amino acids located between residues
23 and 24 (Fig. 2a); otherwise the remaining amino-acid
sequence is identical to that described previously [7]. At
least three different exons can be differentially spliced
into this position [7,10,31] and seven different protein
isoforms of FGF-8 can potentially be generated.
The isolation of cDNAs for multiple fgf-8 splice variants
suggests that alternative splicing might be regulated in a
stage-specific or tissue-specific fashion. Others have exa-
mined these possibilities but reported no difference in
exon usage [10,31]. We used an RNase protection assay
to make a preliminary assessment of different transcript
usage in various regions of the embryo. RNA was pre-
pared from five regions microdissected from 10.5 d.p.c.
embryos - the tail bud, limb buds, trunk (containing the
somites which expressfgf-8 at this stage), midbrain-hind-
brain region and the branchial arches - and hybridized
to an antisense RNA probe spanning the 5' region of the
gene, as depicted in Figure 2a. This probe distinguishes
the fgf-8 variant that we isolated from those containing
additional inserted exons as discussed above [7,10,31].
RNA was detected in all regions of the embryo tested, as
predicted from the in situ hybridization study (Fig. 2b).
However, differences were noted in the relative intensi-
ties of the protected bands. For example, tail bud RNA
(lane 1) contains the 185/189-nucleotide (+ 3 nucleo-
tides) protected bands expected for isoforms containing
an additional inserted exon, but lacks the 307-nucleotide
(+ 3 nucleotides) protected fragment generated by the
novel isoform that we describe. By contrast, other sites
have all of the protected fragments, but there is appar-
ently some variation in their relative intensities between
tissues, suggesting preferential use of certain isoforms.
The reason for the protection of a doublet of fragments
between 185 and 189 nucleotides is not known, although
the published sequence [7] indicates that splicing could
occur one codon after the splice site indicated in Figure
2a, suggesting that a choice of splice donor site could
account for this difference.
Fgf-8 is expressed in the AER of the developing limb bud of
mouse and chicken
Fgf-8 transcripts were detected in the distal region of
developing mouse forelimb and hindlimb buds (Fig. lg,h;
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Fig. 1. Fgf-8 expression in the postimplantation mouse embryo. (a) Sagittal section of a 5.5 d.p.c. embryo showing expression in the
visceral embryonic endoderm (arrow). (b,c) Sagittal (b) and transverse (c) sections of a 6.5 d.p.c. embryo. Fgf-8 RNA is detected in the
ectoderm and mesoderm of the primitive streak region (arrowheads) and the visceral embryonic ectoderm (arrow). (d-h) Whole-
embryo in situ hybridization to: (d) a 2 somite, 8 d.p.c. embryo; (e) a 4 somite, 8 d.p.c. embryo; (f) a 12 somite, 8.75 d.p.c. embryo; (g)
a 26 somite, 9.5 d.p.c. embryo; and (h) a 32 somite, 10 d.p.c. embryo. (i-k) Transverse sections taken through the tail bud region of a
25 somite, 9.5 d.p.c. embryo at progressively more anterior levels show fgf-8 expression in ectoderm, neural plate, mesoderm and
endoderm. (I) Sagittal section of a 12 somite, 8.75 d.p.c. embryo shows weak expression in the myocardium (arrow) and stronger
expression in the branchial region. (m) Transverse section of a somite from a 25 somite embryo; transcripts are detected in the anterior
and posterior margins of the myotome. (n) Coronal and (o) transverse sections taken through the midbrain-hindbrain junction. Tran-
scripts are present between the ventricular and pial surfaces of the neuroepithelium but are excluded from the floorplate and roof plate
(arrows). (p) Coronal section through the forebrain of a 29 somite, 9.75 d.p.c. embryo; transcripts are detected in the neuropore region
(arrow) and the adjacent ectoderm and also at the midbrain-forebrain junction (arrowhead). (q) Sagittal section through the midbrain
and cerebellum of a 14.5 d.p.c. embryo showing restriction of RNA to a region of ventro-posterior midbrain (arrows). (r-t) Transverse
(r,t) and longitudinal (s) sections showing fgf-8 expression in the ectoderm and endoderm of the branchial region of a 25 somite
embryo. Transcripts are detected in the ectoderm of the maxillary and mandibular processes (r), and in a continuous strip of ectoderm
spanning the second, third and fourth arches and the endoderm of the branchial pouches (s,t). The second (II) and third (III) pouches are
shown in (s), and the second in (t). (u) Frontal view of the anterior half of an 11 d.p.c. embryo showing fgf-8 expression in the olfactory
pits, lateral nasal and mandibular processes, the anterior forebrain, apical ectodermal ridges and condensing cartilage at the base of the
limbs (arrow). (v) Expression in the primitive glomeruli (arrows) of the kidney at 14.5 d.p.c. Abbreviations: AER, apical ectodermal
ridge; b, branchial region; ce, cerebellum; cp, cardiogenic plate; d, dermatome; e, ectoderm; en, endoderm ; f, forebrain; ic, intra-
embryonic coelom; hb, hindbrain; i, isthmus (midbrain-hindbrain boundary); md, mandibular process; mx, maxillary process; m,
mesoderm; m-f midbrain-forebrain boundary region; m-h, midbrain-hindbrain region; mb, midbrain; my, myotome; np, neural plate;
op, olfactory pit; ps, primitive streak; sc, sclerotome; s, somite; t, tail bud.
[10,11,31]), and were maintained in this region of the
developing limb until 13.5d.p.c. (data not shown;
[10,11]). In older embryos, fgf-8 RNA was also detected
in condensing cartilage elements at the base of the limbs
(Fig. 1u). Examination of sections of limb bud tissue
showed that transcripts were restricted to cells of the
AER (Fig. 3a). Analysis of the onset of expression indi-
cated thatfgf-8 transcripts were present in the ectoderm
of the presumptive limb territories, prior to the onset of
limb bud outgrowth, at the 17 somite stage, 9.25 d.p.c.
(Fig. 3b,c). Equivalent spatial and temporal expression
was also observed in chicken embryos (Fig. 3d-g), with
expression first detected in the prospective wing territory
at the 27 somite stage (stage 16 as defined by Hamburger
and Hamilton [32]) (Fig. 3d), prior to the first morpho-
logical appearance of the wing bud at stage 17, suggesting
that the function of FGF-8 in the developing vertebrate
limb bud has been conserved during evolution.
Purified FGF-8 protein maintains limb bud outgrowth in the
absence of an AER
The AER is a specialized region of ectoderm extending
along the anterior-posterior axis at the distal tip of the
limb bud; immediately subadjacent to it is a proliferative
region of undifferentiated mesenchyme called the pro-
gress zone. Interaction between the AER and the pro-
gress zone is crucial to the development of the limb:
removal of the AER results in a cessation of limb bud
outgrowth and the development of a truncated limb. The
proximodistal level of the truncation depends upon the
stage of limb bud development at which the manipula-
tion is performed: removal at earlier stages results in more
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proximal truncations [33,34]. Summerbell et al. [35]
encapsulated these results in the 'progress-zone model',
which proposes that the cells of the progress zone are
maintained in an undifferentiated state, are stimulated to
divide, and during outgrowth are assigned progressively
more distal positional identities. Cells leaving the proxi-
mal region of the progress zone differentiate, their posi-
tional 'value' depending on the time at which they left
the progress zone. The AER is believed to regulate these
events by maintaining progress-zone cells in an undiffer-
entiated state, stimulating their division and influencing
their positional value [35-37].
Fgf-4 transcripts are present in the AER of both chicken
and mouse embryos [14,30,38,39], and exogenous FGF-
4 can maintain limb bud outgrowth in limbs from which
the AER has been removed [40,41]. However, transcripts
are restricted to the posterior part of the AER and, as
FGFs are generally believed to act over only short dis-
tances because of interactions with proteoglycans, FGF-4
would not seem to be a good candidate mitogen for
anterior progress-zone cells. FGF-1, FGF-2 and FGF-5
are also mitogens for progress zone cells [40,42], butfgf- 1
and fgf-5 are not detected in the AER ([18] and I.M.,
unpublished data). FGF-2 is widely distributed intra-
cellularly in chicken embryo limb buds, both in the ecto-
derm, including the AER, and in the mesenchyme,
including the progress zone [22,43]. The presence of
FGF-2 in the basal lamina of the AER indicates that it is
secreted in the region of the progress zone, although it is
not clear whether the presence of protein within the
cytoplasm of mesenchymal cells, including progress-zone
cells, is due to synthesis or uptake. By contrast, FGF-8
is constitutively secreted in vitro J.B., C.M. and C.D.,
unpublished observations) and, after its first appearance,
is specifically expressed throughout the AER of the
developing limb, but not in ectoderm adjacent to the
AER. FGF-8 activates FGFR-1 in vitro [9] and fgfr-1
transcripts are present throughout the limb bud mes-
enchyme during this period [24,26]. Taken together,
these data suggest that FGF-8 is a mitogen regulating the
AER-dependent phase of limb bud growth.
Fig. 2. Fgf-8 cDNA sequence and expression in the 10.5 d.p.c.
mouse embryo. (a) DNA sequence of an fgf-8 cDNA isolated by
RT-PCR from SC3 cell RNA. The arrows under the 5' and 3' ends
of the sequence indicate the position of the primers used to
amplify the cDNA. The overlined region shows the extent of the
antisense probe used for the RNase protection analysis illustrated
below, and the 'V' marks the point where alternative exons have
been found inserted in other cDNAs [7,31]. (b) RNase protection
analysis using 30 ,ug total RNA (except for lane 1, where only
10 ig was used) from: tail bud (lane 1), limb buds (lane 2), trunk
(lane 3), midbrain-hindbrain region (lane 4), branchial arches(lane 5) and calf thymus tRNA (lane 6). SP marks the position at
which alternative splicing occurs.
We examined the capacity of FGF-8 to maintain limb bud
outgrowth in cultured mouse embryos in which the AER
had been surgically removed from one forelimb bud.
Under such conditions, embryos develop normally for up
to 48 hours [44], thus restricting the analysis to the initial
period of outgrowth. By 10 d.p.c., prior to the onset of
detectable fgf-4 expression, fgf-8 expression was restricted
to the AER (Fig. 3a). AERs were removed from the left
forelimb bud of 10 d.p.c. embryos, and the mice cultured
with or without exogenous FGF-8 (50 ng ml-1). Control
embryos, incubated without exogenous FGF-8, showed
greatly reduced outgrowth of the operated limb compared
to its contralateral counterpart (Fig. 3h; n = 14, three sep-
arate experiments). By contrast, in the presence of FGF-8,
both forelimbs generally showed approximately equivalent
outgrowth (Fig 3i,j; n = 35, three separate experiments,
two FGF-8 preparations). Similar results were obtained
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Fig. 3. Expression of fgf-8 in the AER of the developing limb of mouse and chick embryos, and stimulation of outgrowth of limbs lacking an
AER by FGF-8. (a-c) Expression of fgf-8 in developing mouse limbs. (a) Transverse section through the limb bud of a 28 somite embryo
shows fgf-8 transcripts restricted to the limb-field ectoderm. (b,c) Onset of fgf-8 expression in the ectoderm of the limb territory (arrows)
precedes outgrowth of the limb bud. Whole-embryo in situ hybridization (b) and radioactive in situ hybridization (c) to 17 somite,
9.25 d.p.c. embryos. (d-g) Expression of fgf-8 in developing chick limbs. (d) Expression of fgf-8 (arrow) in the presumptive wing territory of
a stage 16 (27 somite) chicken embryo; somites are numbered. (e) Expression in the developing wing AER of a stage 18 (34 somite) chick
embryo. (f) Fgf-8 transcripts in the limb-field ectoderm (arrow) of the chicken in a transverse section of a stage 18 embryo. (g) Expression of
fgf-8 (arrows) in the AERs of the wing (w) and leg buds (I) of a stage 22 chicken embryo. (h-k) Regulation of limb bud outgrowth and shh
by FGF-8. (h) Limbs from a control embryo cultured without exogenous FGF-8; the outgrowth of the operated limb bud (o) is significantly
reduced by comparison to the contralateral limb (c). The embryo was subsequently subjected to in situ hybridization using an fgf-8 probe
to confirm the removal of the AER; the intact AER of the control limb bud is labelled. Note that the presence of a few fgf-8-positive cells
(arrow) in the operated limb does not produce significant outgrowth. (i,j) Outgrowth of a mouse forelimb bud lacking an AER is main-
tained when the embryo is cultured in the presence of FGF-8. (i) Transverse slice through the forelimb region of a mouse embryo main-
tained in FGF-8 shows equivalent growth of the operated (o) and contralateral control (c) limb buds. (j) Limbs from an embryo cultured in
FGF-8 showing approximately equivalent outgrowth of the operated (o) and control (c) limbs. (k) Exogenous FGF-8 fails to maintain shh
expression in limbs lacking an AER.
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using exogenous FGF-4 (50 ng ml-1; n = 12, three sepa-
rate experiments) or FGF-8-conditioned medium from
COS cells (n=4, one experiment; data not shown).
In situ hybridization using a probe for forfgf-8 at the end
of these experiments confirmed that the AER had been
completely removed and that fgf-8 expression was not
itself induced in the limb tissue by exogenous FGF-8
protein (Fig. 3i,j). We sometimes observed the presence
of a fewfgf-8-positive cells in control embryos but, in the
absence of exogenous FGF-8, these were not sufficient
by themselves to stimulate significant growth (Fig. 3h). In
about 15 % of embryos, FGF-8 failed to stimulate an
increase in size of the limb bud when compared to con-
trol embryos; we attribute this to the removal of pro-
gress-zone tissue together with the AER. Unlike the
avian AER, which is a large morphologically distinct
structure, the mouse AER is difficult to distinguish from
the underlying mesenchyme at early stages [45].
Measurements were taken between the distal tip of the
limb bud and its ventral insertion into the flank using a
graticule [40,41]. For control embryos, relative outgrowth
was 55 % + 14 % of the contralateral side (data from six
embryos); whereas in embryos exposed to FGF-8, relative
growth was 99 % ± 12 % of the contralateral side (data
from ten embryos). These results are similar to those
obtained with FGF-4 in the chick limb [41]. Outgrowth
was slightly reduced in comparison to studies with FGF-4
in mouse limb [40]. However, the latter experiments were
performed on tissue explants, whereas we used whole
embryos. These data demonstrate that FGF-8, like FGF-
4, can maintain growth of limb buds lacking an AER,
suggesting that FGF-8 maintains both anterior and pos-
terior progress zone cells in vivo. Expression of both mol-
ecules in the posterior AER may account for the increased
growth of the posterior limb bud at later stages.
FGF-8 does not maintain the expression of shh in mouse
limb buds lacking an AER
A second possible function for the AER is in the mainte-
nance of the zone of polarizing activity, which patterns
the limb in its antero-posterior axis [46]. Sonic hedgehog
(shh) is expressed in regions with polarizing activity in
both mouse and chicken embryos [47,48]. Shh protein
can induce polarizing activity in the anterior regions of
avian limb buds [48]. FGF-4, expressed in the posterior
AER, can maintain both shh expression and zone of
polarizing activity in limb buds lacking an AER
[38,39,41,46]. We have investigated the ability of FGF-8
to maintain shh expression following removal of the AER
from the mouse embryo, using the technique described
above. We found that, despite maintaining bud growth,
FGF-8 did not maintain shh expression (Fig. 3k). This
may reflect a functional difference between FGF-4 and
FGF-8, and explain their paradoxical differential expres-
sion patterns within the AER. If true, one would predict
different receptor specificities or affinities for the two
FGF proteins. Alternatively, differences in the mainte-
nance of shh expression may simply reflect the different
modes of FGF application. The results with FGF-4 were
obtained using focal application of unknown, but pro-
bably very large, concentrations of protein in chicken
embryos, in contrast to the global application of nano-
gram per millilitre concentrations of FGF-8 protein used
in these studies. To explore further these and other ques-
tions concerning FGF-8 function in limb patterning, it
will be important to perform experiments in the avian
embryo, because of the limitations of the culture period
possible for mouse embryos.
Possible functions for FGF-8 during the establishment of
limb territory and the initiation of limb bud growth
A striking finding of this study is thatfgf-8 transcripts are
restricted to the ectoderm of the presumptive limb bud
territories (limb-field ectoderm) of both mouse and chic-
ken embryos, prior to the first outgrowth of the limb
buds (Fig. 3b-f). By contrast,fgf-4 transcripts are present
only in the AERs, which develop after significant out-
growth has occurred in these embryos ([14,30,38] and
our unpublished observations). The initial phase of limb
outgrowth, called budding, occurs in the absence of a
morphological AER and studies of a mutant chicken,
limbless, which is unable to form an AER, have suggested
that budding is independent of ridge activity [49]. We
find thatfgf-8 transcripts are present prior to and during
budding in a domain that is more extensive in the dorso-
ventral axis than an AER (Fig. 3c,f). Thus, although the
precise mechanisms of budding and AER-dependent bud
growth may be different, FGF-8 may be an ectodermally
derived mitogen for underlying mesenchyme cells during
both events. In addition, these data raise the intriguing
possibility that the fate of those cells expressing fgf-8
during budding is subsequently to form the AER.
The introduction of cells expressing FGF-2 or FGF-4
expressed from a retrovirus into existing avian limb bud
territories stimulates the duplication of skeletal elements
[50,51]. In one of these studies, FGF-4 induced small
outgrowths outside limb territories, which subsequently
regressed [51]. By contrast, the ability of FGF-coated
heparin-acrylic beads to stimulate the formation of ecto-
pic limbs from flank regions between the normal wing
and limb territories of avian embryos have suggested that
an FGF may also function in the establishment of the
limb fields [52]. Fgf-8 is present in the presumptive limb-
field ectoderm prior to outgrowth, suggesting that it may
function in the establishment of the fields, although
mesodermal cues are also undoubtedly important [53,54].
Whether FGF-8 can stimulate the formation of ectopic
limbs remains to be tested. Intriguingly, olfactory tissue,
which we and others find expressesfgf-8, induces ectopic
limbs in the flanks of amphibians [55].
Conclusions
We have shown that fgf-8 transcripts are present in the
ectoderm of limb bud territories prior to the onset of
limb bud growth in both mouse and chicken embryos,
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and persist in the AER during the early development of
the limb. Removal of the AER results in the cessation of
outgrowth, and this effect can be rescued by the applica-
tion of exogenous FGF-8. Thus FGF-8 is a good candi-
date for being an AER-derived mitogenic activity that
regulates limb bud outgrowth. FGF-8 may also regulate
the AER-independent budding process which occurs at
the onset of limb growth.
Materials and methods
Isolation offgf-8 cDNA clones and in situ hybridization
analyses
Fgf-8 was cloned from the SC3 cell line by RT-PCR using
primers selected from non-coding regions of the published
sequence [7]. The 5' primer incorporated an EcoRl restriction
endonuclease site to facilitate subsequent subcloning manipula-
tions, but the original PCR fragment was cloned into the
EcoRV site of pBluescript SK- (Stratagene, La Jolla) by the
T-A strategy [56]. The cDNA was sequenced directly using
SequenaseT M , as described by the manufacturers (Amersham
International). In situ hybridization to mouse embryos and sub-
sequent sectioning of embryonic tissue has been described else-
where ([27] and K. Robertson and I.M., manuscript sub-
mitted). Reduced stringency hybridization to chicken embryos
was undertaken using a protocol provided by D. Ish-Horowicz
(D. Henrique and D. Ish-Horowicz, manuscript in preparation;
available on Internet by anonymous ftp from ftp://ftp.lif.
icnet.uk/icrf-public/recipes/insiturecipel l_95.hqx) with the
following modifications: hybridization was carried out at 50 °C
and post-hybridization washes were at 55 C. The shh probe
was identical to that used by others [47].
RNase protection analyses
RNase protection analyses were performed as described previ-
ously [57]. Briefly, a HindIII-Hinfi fragment from the fgf:8
cDNA (see Fig. 2) was subcloned into pBluescript KS-. To
prepare labelled antisense riboprobes, the plasmid was lin-
earized at the unique HindIII site within the polylinker and in
vitro transcribed in the presence of [32 P]UTP. The probes were
purified by preparative gel electrophoresis and hybridized to
total cellular RNA preparations (30 jIg) [58] from micro-
dissected embryonic tissue. Calf liver tRNA was used as a
negative control. Following digestion with ribonucleases A and
T1, the resistant duplexes were analyzed by denaturing poly-
acrylamide gel electrophoresis and the sizes of protected frag-
ments were estimated relative to a DNA sequence ladder.
Preparation of FGF-8 protein
Fgf-8 cDNA was subcloned as a 760 base-pair fragment into the
expression vector pKC3 and introduced into COS-1 cells by
electroporation as previously described [59]. To purify FGF-8,
cell-culture supernatants were harvested after 48-72 h and sub-
ject to heparin-Sepharose chromatography as described [59].
Studies of mouse limb bud outgrowth following surgical
removal of AERs
Mouse embryos at 10 d.p.c. (staged by limb development) were
explanted as described [44] and maintained in L-15 (Leibovitz)
medium (Life Technologies, Paisley, UK). The AER was dis-
sected from their left forelimb buds with flame-sharpened tung-
sten needles. Embryos were cultured for 24-30 h in Tyrodes
saline containing 75 % rat serum, 100 U ml-1 penicillin, 100 [ig
ml- streptomycin, 1 ig ml- I heparin (Sigma No. H-7005),
either with or without 50 ng ml-l purified FGF-8 in an atmos-
phere of 95 % oxygen as described [44]. Oxygen was replen-
ished after 6 and 18 h. In some experiments, 10 % v/v condi-
tioned medium from COS cells transfected with either fgf-8,
fgf-4 or vector alone was used in place of purified FGF. Fol-
lowing culture, embryos were fixed in 4 % w/v paraformal-
dehyde in PBS prior to subsequent analyses.
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